Patent ID: 7842677

Claim:
A synthetic compound having a formula selected from the group consisting of (Va), (Vb), (Vc) and (Vd): wherein the saccharide portion is selected from the group consisting of X is NR 1 R 2 ; Y is —OH; Z is O; each R 1 and R 2 are independently selected from the group consisting of —C(=M)R 3 , and —C(=M)-p-R 3 ; wherein M and p are independently selected from O, NR 4 and S; R 3 is H, alkyl, arylalkyl, haloalkyl, aryl, heteroaryl, or heteroalkyl; R 4 is H, alkyl, aryl, arylalkyl, heteroaryl, heteroalkyl, or haloalkyl; R 6 is H; R 6′ is —NR 9 R 10 ; R 6 ″ is H; R 7 and R 8 are independently H, and aryl, where, R 7 and R 8 are optionally substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl; R 7′ and R 8′ are independently H, alkenyl, —C(═O)NR 9 R 10 , aryl, heteroaryl, or a linked bicyclic mixture of aryl and heteroaryl, where R 7′ and R 8′ are optionally substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl; R 9 , R 10 , and R 11 are independently alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, or heteroalkyl, where R 9 , R 10 , and R 11 are optionally substituted, preferably-substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl; or where R 9 and R 10 taken together with the nitrogen to which they are attached form a heterocyclic ring comprising at least one heteroatom selected from N, O and S; and all pharmaceutically acceptable salts, and geometric isomers thereof.